Noriyoshi Ishikawa
Overview
Explore the profile of Noriyoshi Ishikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
541
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanno K, Nakayama K, Razia S, Islam S, Farzana Z, Sonia S, et al.
Curr Issues Mol Biol
. 2024 Sep;
46(9):9376-9385.
PMID: 39329907
Ovarian cancer is classified as type 1 or 2, representing low- and high-grade serous carcinoma (LGSC and HGSC), respectively. LGSC arises from serous borderline tumor (SBT) in a stepwise manner,...
2.
Kitagawa I, Ishikawa N, Ono R
IDCases
. 2024 May;
36:e01941.
PMID: 38699525
is a Gram-positive coccus that can be easily misidentified as spp. or streptococci. Infection with is associated with the consumption of raw fish and unpasteurized dairy products. Although rare, it...
3.
Ishikawa M, Nakayama K, Razia S, Yamashita H, Ishibashi T, Haraga H, et al.
Curr Issues Mol Biol
. 2023 May;
45(4):2908-2916.
PMID: 37185714
Herein, we present the successful treatment of a 92-year-old woman who experienced recurrent EC in the vaginal stump and para-aortic lymph nodes. The patient was first treated with paclitaxel and...
4.
Sasamori H, Nakayama K, Razia S, Yamashita H, Ishibashi T, Ishikawa M, et al.
Curr Oncol
. 2022 May;
29(5):3658-3667.
PMID: 35621684
Ovarian seromucinous tumors (SMBTs) are relatively rare, and their carcinogenesis is largely unknown. In this study, the molecular features of SMBTs in Japan are assessed. DNA was extracted from microdissected...
5.
Kawashima K, Oshima N, Kishimoto K, Kataoka M, Fukunaga M, Kotani S, et al.
Inflamm Bowel Dis
. 2022 May;
29(3):359-366.
PMID: 35583193
Background: Consensus regarding the cutoff value of fecal calprotectin (FC) for predicting histological healing (HH) in ulcerative colitis (UC) is lacking. This study aimed to determine an optimal FC cutoff...
6.
Yoshida R, Yoshizako T, Okamura K, Ando S, Nakamura M, Ishikawa N, et al.
Acta Radiol Open
. 2022 Apr;
11(3):20584601221080514.
PMID: 35392629
Elastofibroma dorsi is a well-known benign chest wall tumor. Herein, we present a case in which an elastofibroma protruded into the thoracic cavity, leading to inverted intercostal hernia. Imaging revealed...
7.
Mitarai Y, Nakashima K, Fukunaga S, Ishikawa N, Ito T, Tsubata Y, et al.
Intern Med
. 2021 Nov;
61(13):2013-2017.
PMID: 34840226
A 70-year-old man received pembrolizumab as a second-line treatment for squamous cell lung cancer of the lower right lobe. After three courses, proteinuria and hematuria were observed, which worsened after...
8.
Ishikawa M, Nakayama K, Yamashita H, Ishibashi T, Sato S, Kurose S, et al.
Mol Clin Oncol
. 2021 Oct;
15(6):250.
PMID: 34671469
The treatment of cervical intraepithelial neoplasia (CIN) can result in under- or overtreatment. The current report describes a case of undertreatment of a cervical tumor. A 72-year-old woman was preoperatively...
9.
Ishikawa M, Nakayama K, Nakamura K, Yamashita H, Ishibashi T, Minamoto T, et al.
Sci Rep
. 2021 Sep;
11(1):18236.
PMID: 34521948
Previous studies have largely failed to clarify the relationship between p16 status and cervical adenocarcinoma prognosis. The current study aimed to examine the clinical and pathological significance of p16 expression...
10.
Taira M, Matsumura T, Sumita Y, Moriyama M, Kondo M, Ishikawa N, et al.
Intern Med
. 2021 Aug;
61(4):559-565.
PMID: 34433711
Acute fibrinous and organizing pneumonia (AFOP) is rare in patients with systemic lupus erythematosus (SLE). We herein report a case of AFOP with SLE and hemophagocytic syndrome. Early-phase high-resolution computed...